Delivery Order SPE2DB20D3303-SPE2DB25FA3XF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $5,207.81. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 26, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $14,115.27 to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Latuda is an atypical antipsychotic medication commonly used to treat schizophrenia and bipolar...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,787.95 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by May 7, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract action under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $28,377.71 by the Defense Logistics Agency to supply Latuda 20 mg tablets (30-count packages). This firm fixed price, competitively awarded contract was issued on June 9, 2025, with an ultimate completion date of June 10, 2025. The pharmaceutical products will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $41,891.62. This firm fixed-price contract, awarded on September 8, 2025, with a completion date of September 9, 2025, represents a non-competitive set-aside delivery order issued under DLA's broader pharmaceutical procurement framework. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Latuda 60 mg, a medication used to treat bipolar disorder and schizophrenia, valued at $3,040.56. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- This is a $9,596.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Latuda 40 mg tablets and has a period of performance through July 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3XFDelivery Order
The Defense Logistics Agency awarded a $6,978.90 delivery order to AmerisourceBergen Drug Corp for Latuda 40 mg tablets (30-count units) on September 18, 2025, with a completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and reflects firm fixed pricing terms. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying pharmaceuticals and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Latuda (lurasidone) is an atypical antipsychotic medication used to treat schizophrenia and bipolar depression, representing the type of specialized neurological and psychiatric treatment within AmerisourceBergen's extensive pharmaceutical portfolio delivered to military and veteran healthcare systems. This delivery order exemplifies the company's role in supporting the DLA Medical Supply Chain through flexible contract vehicles that enable rapid fulfillment of pharmaceutical needs across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 9/18/25 |